Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prediction of macroscopic findings of hepatocellular carcinoma on hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with pathology.
Fujinaga Y, Kadoya M, Kozaka K, Shinmura R, Matsui O, Takayama T, Yamamoto M, Kokudo N, Kawasaki S, Arii S. Fujinaga Y, et al. Among authors: arii s. Hepatol Res. 2013 May;43(5):488-94. doi: 10.1111/j.1872-034X.2012.01089.x. Epub 2012 Sep 16. Hepatol Res. 2013. PMID: 22978417
Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Kaneko S, Nakashima O, Kadoya M, Izumi N, Takayama T, Ku Y, Kumada T, Kubo S, Kokudo T, Hagiwara Y, Kokudo N; Liver Cancer Study Group of Japan. Takayasu K, et al. Among authors: arii s. Liver Int. 2018 Mar;38(3):484-493. doi: 10.1111/liv.13670. Epub 2018 Jan 25. Liver Int. 2018. PMID: 29266722
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
Kokudo N, Hasegawa K, Akahane M, Igaki H, Izumi N, Ichida T, Uemoto S, Kaneko S, Kawasaki S, Ku Y, Kudo M, Kubo S, Takayama T, Tateishi R, Fukuda T, Matsui O, Matsuyama Y, Murakami T, Arii S, Okazaki M, Makuuchi M. Kokudo N, et al. Among authors: arii s. Hepatol Res. 2015 Jan;45(2). doi: 10.1111/hepr.12464. Hepatol Res. 2015. PMID: 25625806
Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan.
Kudo M, Matsui O, Sakamoto M, Kitao A, Kim T, Ariizumi S, Ichikawa T, Kobayashi S, Imai Y, Izumi N, Fujinaga Y, Arii S. Kudo M, et al. Among authors: arii s. Oncology. 2013;84 Suppl 1:21-7. doi: 10.1159/000345885. Epub 2013 Feb 20. Oncology. 2013. PMID: 23428854
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang X, Kaneko S. Yamashita T, et al. Among authors: arii s. Hepatology. 2014 Nov;60(5):1674-85. doi: 10.1002/hep.27093. Epub 2014 Sep 29. Hepatology. 2014. PMID: 24700365 Free PMC article. Clinical Trial.
334 results